TY - JOUR
T1 - Liver Transplantation for Fulminant Hepatic Failure
T2 - Experience with More Than 200 Patients over a 17-Year Period
AU - Farmer, Douglas G.
AU - Anselmo, Dean M.
AU - Ghobrial, R. Mark
AU - Yersiz, Hasan
AU - McDiarmid, Suzanne V.
AU - Cao, Carlos
AU - Weaver, Michael
AU - Figueroa, Jesus
AU - Khan, Khurram
AU - Vargas, Jorge
AU - Saab, Sammy
AU - Han, Steven
AU - Durazo, Francisco
AU - Goldstein, Leonard
AU - Holt, Curtis
AU - Busuttil, Ronald W.
AU - Klein, Andrew S.
AU - Henderson, J. Michael
AU - Steinberg, Steven M.
PY - 2003/5
Y1 - 2003/5
N2 - Objective: To analyze outcomes after liver transplantation (LT) in patients with fulminant hepatic failure (FHF) with emphasis on pretransplant variables that can potentially help predict posttransplant outcome. Summary Background Data: FHF is a formidable clinical problem associated with a high mortality rate. While LT is the treatment of choice for irreversible FHF, few investigations have examined pretransplant variables that can potentially predict outcome after LT. Methods: A retrospective review was undertaken of all patients undergoing LT for FHF at a single transplant center. The median follow-up was 41 months. Thirty-five variables were analyzed by univariate and multivariate analysis to determine their impact on patient and graft survival. Results: Two hundred four patients (60% female, median age 20.2 years) required urgent LT for FHF. Before LT, the majority of patients were comatose (76%), on hemodialysis (16%), and ICU-bound. The 1- and 5-year survival rates were 73% and 67% (patient) and 63% and 57% (graft). The primary cause of patient death was sepsis, and the primary cause of graft failure was primary graft nonfunction. Univariate analysis of pre-LT variables revealed that 19 variables predicted survival. From these results, multivariate analysis determined that the serum creatinine was the single most important prognosticator of patient survival. Conclusions: This study, representing one of the largest published series on LT for FHF, demonstrates a long-term survival of nearly 70% and develops a clinically applicable and readily measurable set of pretransplant factors that determine posttransplant outcome.
AB - Objective: To analyze outcomes after liver transplantation (LT) in patients with fulminant hepatic failure (FHF) with emphasis on pretransplant variables that can potentially help predict posttransplant outcome. Summary Background Data: FHF is a formidable clinical problem associated with a high mortality rate. While LT is the treatment of choice for irreversible FHF, few investigations have examined pretransplant variables that can potentially predict outcome after LT. Methods: A retrospective review was undertaken of all patients undergoing LT for FHF at a single transplant center. The median follow-up was 41 months. Thirty-five variables were analyzed by univariate and multivariate analysis to determine their impact on patient and graft survival. Results: Two hundred four patients (60% female, median age 20.2 years) required urgent LT for FHF. Before LT, the majority of patients were comatose (76%), on hemodialysis (16%), and ICU-bound. The 1- and 5-year survival rates were 73% and 67% (patient) and 63% and 57% (graft). The primary cause of patient death was sepsis, and the primary cause of graft failure was primary graft nonfunction. Univariate analysis of pre-LT variables revealed that 19 variables predicted survival. From these results, multivariate analysis determined that the serum creatinine was the single most important prognosticator of patient survival. Conclusions: This study, representing one of the largest published series on LT for FHF, demonstrates a long-term survival of nearly 70% and develops a clinically applicable and readily measurable set of pretransplant factors that determine posttransplant outcome.
UR - http://www.scopus.com/inward/record.url?scp=0038521242&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0038521242&partnerID=8YFLogxK
U2 - 10.1097/00000658-200305000-00009
DO - 10.1097/00000658-200305000-00009
M3 - Article
C2 - 12724633
AN - SCOPUS:0038521242
VL - 237
SP - 666
EP - 676
JO - Annals of surgery
JF - Annals of surgery
SN - 0003-4932
IS - 5
ER -